Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus (original) (raw)

Nature volume 291, pages 590–591 (1981)Cite this article

Abstract

Thromboembolism is a frequent and often lethal complication of many medical diseases and surgical procedures. Streptokinase, a bacterial non-enzymatic protein, and urokinase, an enzyme obtained from human urine, are both potent activators of the human fibrinolytic system, and have been extensively investigated as a means of medical treatment of this condition. Although it is well established that these agents can clear obstructed vessels in roughly 50% of cases, the fact that they induce relatively extensive systemic fibrinogen breakdown and a serious haemorrhagic diathesis has prevented their general application for thrombolysis. The physiological plasminogen activator in blood (blood activator), which is probably released from the vascular wall (vascular activator) and is identical or at least very similar to the activator extracted from human organs (tissue activator), differs from urokinase (for references see ref. 1). This activator has a markedly higher fibrinolytic to fibrinogenolytic ratio than urokinase _in vitro_1 and might therefore constitute a better thrombolytic agent. We have developed a purification method for tissue plasminogen activator from a human melanoma cell line which enables us to produce milligramme quantities on a laboratory bench scale2 and we have now compared its thrombolytic effect with that of urokinase in an experimental animal model. We have found that tissue plasminogen activator causes thrombolysis at lower doses than urokinase, without extensive plasminogen activation in the circulating blood and without haemostatic breakdown.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Matsuo, O., Rijken, D. C. & Collen, D. Thromb. Haem. (in the press).
  2. Rijken, D. C. & Collen, D. J. biol Chem. (in the press).
  3. Astrup, T. & Müllertz, S. Archs Biochem. Biophys. 40, 346–351 (1952).
    Article CAS Google Scholar
  4. Rijken, D. C., Wijngaards, G., Zaal-De Jong, M. & Welbergen, J. Biochim. biophys. Acta 580, 140–153 (1979).
    Article CAS Google Scholar
  5. Blombäck, B. & Blombäck, M. Ark. Kemi 10, 415–423 (1956).
    Google Scholar
  6. McFarlane, A. S. Nature 182, 53 (1958).
    Article ADS CAS Google Scholar
  7. Friberger, P. & Knös, M. in Chromogenic Peptide Substrates (eds Scully, M. F. & Kakkar, V. V.) 128–140 (Churchill Livingstone, Edinburgh, (1979).
    Google Scholar
  8. Edy, J., De Cock, F. & Collen, D. Thromb. Res. 8, 513–518 (1976).
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Center for Thrombosis and Vascular Research, Department of Medical Research, University of Leuven, Belgium
    O. Matsuo, D. C. Rijken & D. Collen

Authors

  1. O. Matsuo
    You can also search for this author inPubMed Google Scholar
  2. D. C. Rijken
    You can also search for this author inPubMed Google Scholar
  3. D. Collen
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Matsuo, O., Rijken, D. & Collen, D. Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus.Nature 291, 590–591 (1981). https://doi.org/10.1038/291590a0

Download citation

This article is cited by